Ascorbic acid Recruiting Phase 2 Trials for Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02344355A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme